Aloe vera bioink yields immune-smart 3D-printed bone organoids

Scientists have unveiled a recipe for growing miniature pieces of bone that come with their own immune instruction manual, and the key ingredient may already be sitting on a windowsill: aloe vera. In a detailed protocol published in iScience, researchers describe how to fabricate what they call immune-regulatory bone organoids using a plant-based bioink that replaces Matrigel, the animal-derived gel that has long dominated organoid culture. The work addresses two stubborn problems at once: the poor reproducibility of tumor-derived scaffold materials and the neglect of immune cells in most bone engineering platforms, despite the fact that macrophages orchestrate nearly every stage of functional bone repair.

The team, led by researchers including Tianhao Wang and Xiaoxiang Ren, defines its constructs as scaffold-guided engineered bone organoids, meaning the biomaterial establishes the initial three-dimensional architecture while the encapsulated cells progressively take over, depositing bone-specific extracellular matrix and driving mineralization. This dynamic remodeling is what separates a true organoid from a passive cell-laden scaffold. Conventional bone organoid platforms are largely built to push stem cells toward osteogenic differentiation, but they rarely incorporate immune components, a significant drawback given that macrophages must typically shift from a pro-inflammatory M1 state to a pro-regenerative M2 state to resolve inflammation, induce new vessel formation, and facilitate matrix remodeling during healing.

The new bioink blends three components in a carefully optimized ratio of 10 percent gelatin methacryloyl (GelMA), 1 percent Laponite synthetic nanoclay, and 40 percent aloe vera gel. Each ingredient earns its place through a defined function. GelMA, a photocrosslinkable derivative of gelatin, carries the arginine-glycine-aspartic acid cell-adhesion motif and offers tunable mechanics through rapid UV cross-linking. Laponite forms what materials scientists describe as a house-of-cards microstructure, imparting strong shear-thinning behavior that makes the ink extrusion-printable while boosting elastic modulus and toughness; its degradation products, magnesium and silicon ions, have independently been shown to foster a pro-regenerative microenvironment. Aloe vera serves as the immunologically active component, delivering bioactive polysaccharides such as acemannan along with phytosphingosine- and polyphenol-related metabolites identified by liquid chromatography-mass spectrometry.

Reaching that sweet-spot formulation required systematic trade-off analysis. Lower GelMA concentrations produced weak mechanical support and structural collapse, while higher levels restricted cell migration and matrix remodeling. Laponite at 1 percent elevated shape fidelity to a printability coefficient near 1.0, but higher loadings clogged nozzles and pushed cell viability below 80 percent through elevated shear stress. Aloe vera below the optimal threshold weakened immunomodulatory efficacy, whereas excess diluted the precursor and compromised cross-linking. The final formulation, seeded with rat bone marrow mesenchymal stem cells at one million cells per milliliter, yielded continuous filament deposition, precise architecture, and post-printing viability exceeding 90 percent, all without a single exogenous cytokine such as IL-4.

The printing parameters themselves are a study in delicacy. Constructs were extruded at 8 degrees Celsius to preserve gel consistency and prevent filament deformation, under pneumatic pressure of 0.2 to 0.3 megapascals at a speed of 4 millimeters per second, using a 21-gauge metal nozzle. A rectangular, eight-layer porous grid of 5 by 5 millimeters was built with 1.5-millimeter infill spacing and 90-degree interlayer rotation. Cross-linking used 365-nanometer UV light at just 5 percent intensity, applied for 10 seconds per layer with brief post-curing, enough to lock in shape without damaging the stem cells. Printed precursors then spent 24 hours in growth medium before switching to osteogenic induction medium supplemented with beta-glycerophosphate, ascorbic acid, and dexamethasone for up to 28 days.

In vitro, the organoids behaved as hoped. Alkaline phosphatase and Alizarin Red S staining documented progressive osteogenic differentiation and mineral deposition, confirmed by elevated expression of the master osteogenic markers OCN, RUNX2, and OPN and by micro-computed tomography detection of mineralized matrix. On the immune side, the constructs increased macrophage recruitment, invasion, and adhesion, and shifted the cells toward a CD206-positive, iNOS-low phenotype characteristic of pro-regenerative M2 macrophages, accompanied by reduced IL-1beta and increased IL-10 expression. Bulk RNA sequencing of implanted constructs revealed broad immune remodeling across Th1/Th2/Th17-related pathways and alterations in STAT6, NF-kappaB, PI3K/AKT, and RANKL-related signaling, consistent with enhanced pro-regenerative responses and dampened inflammation, though the authors caution these associations do not yet establish direct causality.

The in vivo results are where the platform becomes genuinely striking. When implanted subcutaneously into nude mice, the organoid precursors matured into bone-like tissue, organizing type 1 collagen and periostin into structured extracellular matrix, forming vinculin-positive focal adhesions, and sprouting prominent surface capillaries alongside internal CD31-positive microvascular networks. The team then moved to the decisive test: bilateral 5-millimeter critical-sized calvarial defects in rats, wounds too large to heal on their own. By eight weeks, the aloe-containing organoids had promoted more robust bone regeneration than GelMA-only or GelMA/Laponite control scaffolds, with improved mineralized bone formation, closer integration with host tissue, and CD206-positive macrophages populating the repair site. Histology of major organs and routine blood biochemistry revealed no obvious systemic toxicity.

The authors are candid about the platform’s limits. The protocol models macrophage-mediated regulation only; neutrophils, osteoclasts, T cells, and other stromal populations were not systematically incorporated, and the use of immunodeficient nude mice precludes assessment of adaptive immunity. Late-stage osteocyte maturation and lacuno-canalicular network organization remain uncharacterized, and the eight-week observation window captures only early-to-intermediate regeneration, leaving scaffold degradation kinetics, vascular stabilization, and biomechanical load-bearing integration for future studies extending to 12 to 24 weeks and, ultimately, large-animal models. Batch-to-batch consistency of aloe vera gel also emerges as a critical quality-control point, since variability in its bioactive constituents could weaken macrophage polarization.

Even so, the implications extend well beyond the skull. The researchers envision adapting the bioink to model immune-dysregulated orthopedic diseases such as rheumatoid arthritis and osteoporosis by incorporating patient-derived macrophages, synovial fibroblasts, or osteoclast precursors. Adding chondrogenic factors like TGF-beta3 could generate cartilage organoids, while the same immunoregulatory chemistry might improve wound repair and reduce scarring in skin models. Because the constructs simultaneously promoted bone formation and vascularization in vivo, the system could also help solve the vascularization bottleneck that plagues the engineering of many other tissues. Multi-nozzle bioprinting and microfluidic culture could eventually arrange bone-forming, vascular, and marrow-like compartments in spatially organized, immunocompetent constructs. For a field long tethered to an ill-defined gel extracted from mouse tumors, a printable, plant-powered alternative that teaches immune cells to heal rather than inflame marks a genuinely consequential turn in the organoid revolution.

Subject of Research: Fabrication of immune-regulatory bone organoids using a plant-based GelMA/Laponite/Aloe vera bioink

Article Title: Protocol for fabricating immune-regulatory bone organoids via plant-based bioinks

Article References: Wang, T., Gao, G., Zhang, X., Huo, K., Liu, C., Geng, Z., Bai, L., Zhang, H., Liu, H., Xu, K., Lai, Y., Wang, J., Jing, Y., He, C., Wang, G., Su, J., & Ren, X. (2026). Protocol for fabricating immune-regulatory bone organoids via plant-based bioinks. iScience, 29(11), Article 117866. https://doi.org/10.1016/j.isci.2026.117866

Image Credits: AI Generated

DOI: 10.1016/j.isci.2026.117866

Keywords: bone organoids, bioink, Aloe vera, GelMA, Laponite, 3D bioprinting, macrophage polarization, osteoimmunology, bone regeneration, Matrigel-free, tissue engineering, calvarial defect